Rapport Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RAPP and other ETFs, options, and stocks.

About RAPP

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform.

CEO

Abraham N. Ceesay

CEOAbraham N. Ceesay

Employees

Employees69

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2022

Founded2022

Employees

Employees69

RAPP Key Statistics

Market cap

387.59M

Market cap387.59M

Price-Earnings ratio

-4.96

Price-Earnings ratio-4.96

Dividend yield

—

Dividend yield—

Average volume

122.81K

Average volume122.81K

High today

$11.31

High today$11.31

Low today

$10.45

Low today$10.45

Open price

$10.96

Open price$10.96

Volume

70.92K

Volume70.92K

52 Week high

$29.74

52 Week high$29.74

52 Week low

$6.43

52 Week low$6.43

Rapport Therapeutics

Why Robinhood?

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. Show more

RAPP Key Statistics

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform.